In short
This article discusses the use of Sodium Phosphate Dodecahydrate in clinical trials for treating childhood asthma. While the primary focus of the study is on azithromycin, Sodium Phosphate Dodecahydrate is included as part of the trial. The research aims to explore new treatment options for children aged 1-5 years who are hospitalized due to asthma-like symptoms.
At a glance
- Study Type
- Therapeutic exploratory (Phase II)
- Primary Drug
- Azithromycin
- Secondary Drug
- Sodium Phosphate Dodecahydrate
- Target Condition
- Childhood asthma
- Age Group
- 1-5 years (12-71 months)
- Primary Objective
- Investigate effect of three-day azithromycin treatment vs. placebo
- Secondary Objectives
- Examine individual treatment response, contribute to personalized treatment
- Study Design
- Double-blind, randomized, controlled study
- Primary Endpoint
- Duration of asthma-like episode from start of randomization
What is Sodium Phosphate Dodecahydrate?
Sodium Phosphate Dodecahydrate is a chemical compound that is being studied for its potential medical applications. It is a form of sodium phosphate that contains twelve water molecules, hence the term "dodecahydrate" in its name.
Medical Uses
While the specific medical uses of Sodium Phosphate Dodecahydrate are still being investigated, it is often used in pharmaceutical formulations. In the context of the clinical trial data provided, it is being studied as part of a placebo formulation in a trial related to childhood asthma.
It's important to note that in this trial, Sodium Phosphate Dodecahydrate is not the active treatment being tested. Instead, it is part of the placebo, which is a substance that looks like the real treatment but doesn't contain the active drug. Placebos are crucial in clinical trials to help researchers determine the true effects of the drug being studied.
Administration
According to the clinical trial information, Sodium Phosphate Dodecahydrate is being administered as an oral solution. This means it's a liquid that is taken by mouth.
Current Clinical Trials
The clinical trial mentioned in the data is studying the use of azithromycin (an antibiotic) for treating hospitalized children aged 1-5 years with asthma symptoms. In this study, Sodium Phosphate Dodecahydrate is part of the placebo formulation.
The main objectives of this trial are:
- To investigate the effect of a three-day azithromycin treatment versus placebo in children hospitalized due to asthma-like symptoms.
- To examine individual responses to treatment, potentially contributing to personalized treatment approaches in the future.
- To increase understanding of how bacteria influence asthma-like episodes in preschool children.
Precautions and Side Effects
As Sodium Phosphate Dodecahydrate is part of a placebo formulation in this trial, specific side effects related to this compound are not discussed in the provided data. However, it's always important to inform your healthcare provider about any medications or supplements you're taking, including those in clinical trials.
If you're participating in a clinical trial or considering doing so, always discuss potential risks and benefits with your healthcare provider and the research team. They can provide you with the most up-to-date and relevant information for your specific situation.